First assessment of elosulfase (Vimizin) early access program for a group of 7 Spanish pediatric patients with Morquio A disease

Data de publicación
2015Título da revista
JOURNAL OF INHERITED METABOLIC DISEASE
Tipo de contido
Publicación de congreso
